Oncology Institute (TOI) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free TOI Stock Alerts $0.64 -0.03 (-5.08%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Oncology Institute Short Interest DataCurrent Short Volume268,400 sharesPrevious Short Volume252,000 sharesChange Vs. Previous Month+6.51%Dollar Volume Sold Short$284,504.00Short Interest Ratio / Days to Cover2.2Last Record DateApril 30, 2024Outstanding Shares74,310,000 sharesFloat Size31,090,000 sharesShort Percent of Float0.86%Today's Trading Volume328,600 sharesAverage Trading Volume139,699 sharesToday's Volume Vs. Average235% Short Selling Oncology Institute ? Sign up to receive the latest short interest report for Oncology Institute and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTOI Short Interest Over TimeTOI Days to Cover Over TimeTOI Percentage of Float Shorted Over Time Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). Oncology Institute Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024268,400 shares $284,504.00 +6.5%0.9%2.2 $1.06 4/15/2024252,000 shares $299,880.00 -4.1%0.8%2.2 $1.19 3/31/2024262,700 shares $415,066.00 +12.1%0.8%2.1 $1.58 3/15/2024234,300 shares $393,624.00 +3.8%0.8%1.7 $1.68 2/29/2024225,700 shares $424,316.00 -7.0%0.7%1.2 $1.88 2/15/2024242,600 shares $434,254.00 -20.8%0.8%1.1 $1.79 Get the Latest News and Ratings for TOI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024306,200 shares $627,710.00 -7.5%1.0%1.1 $2.05 1/15/2024330,900 shares $684,963.00 +20.3%0.8%1.1 $2.07 12/31/2023275,000 shares $561,000.00 +51.3%0.7%0.9 $2.04 12/15/2023181,800 shares $245,430.00 -35.0%0.7%0.6 $1.35 11/30/2023279,800 shares $478,458.00 -37.4%1.1%1 $1.71 11/15/2023447,000 shares $992,340.00 +91.3%1.7%1.8 $2.22 10/31/2023233,700 shares $446,367.00 -4.6%0.9%1 $1.91 10/15/2023245,000 shares $379,750.00 -8.8%0.9%1.2 $1.55 9/30/2023268,500 shares $375,900.00 +6.2%1.0%1 $1.40 9/15/2023252,900 shares $417,285.00 -11.9%1.0%0.9 $1.65 8/31/2023286,900 shares $332,804.00 -17.9%0.9%0.4 $1.16 8/15/2023349,300 shares $299,629.54 +42.0%1.1%0.4 $0.86 7/31/2023246,000 shares $240,440.40 -45.3%0.8%0.3 $0.98 7/15/2023450,000 shares $319,635.00 -7.3%1.4%0.5 $0.71 6/30/2023485,400 shares $267,067.08 -74.3%1.5%0.6 $0.55 6/15/20231,890,000 shares $1.14 million +39.0%6.0%2.4 $0.61 5/31/20231,360,000 shares $581,400.00 +5.4%4.4%2.1 $0.43 5/15/20231,290,000 shares $580,500.00 +1.6%4.1%6.6 $0.45 4/30/20231,270,000 shares $647,700.00 +5.8%4.1%7.4 $0.51 4/15/20231,200,000 shares $716,760.00 +2.6%3.9%6.9 $0.60 3/31/20231,170,000 shares $793,143.00 +13.6%3.8%7.2 $0.68 3/15/20231,030,000 shares $682,066.00 +12.0%3.5%5.7 $0.66 2/28/2023919,300 shares $1.30 million -21.4%3.2%6.7 $1.41 2/15/20231,170,000 shares $1.83 million -14.6%4.0%6.9 $1.56 1/31/20231,370,000 shares $2.03 million +31.7%4.7%7.1 $1.48 1/15/20231,040,000 shares $1.77 million +4.0%3.6%5.2 $1.70 12/30/20221,000,000 shares $1.65 million -8.3%3.8%5.1 $1.65 12/15/20221,090,000 shares $1.00 million +39.6%4.2%5.6 $0.92 11/30/2022780,600 shares $1.10 million -17.0%3.0%3.9 $1.41 11/15/2022940,500 shares $1.92 million -3.4%3.6%5.6 $2.04 10/31/2022973,100 shares $4.42 million -8.2%3.7%7 $4.54 10/15/20221,060,000 shares $4.71 million -18.5%4.1%8.4 $4.44 9/30/20221,300,000 shares $6.02 million +46.7%5.1%10.8 $4.63 9/15/2022886,100 shares $4.08 million -6.6%3.5%6 $4.61Shocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company TOI Short Interest - Frequently Asked Questions What is Oncology Institute's current short interest? Short interest is the volume of Oncology Institute shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 268,400 shares of TOI short. 0.86% of Oncology Institute's shares are currently sold short. Learn More on Oncology Institute's current short interest. What is a good short interest ratio for Oncology Institute? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TOI shares currently have a short interest ratio of 2.0. Learn More on Oncology Institute's short interest ratio. What is a good short interest percentage for Oncology Institute? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.86% of Oncology Institute's floating shares are currently sold short. Is Oncology Institute's short interest increasing or decreasing? Oncology Institute saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 268,400 shares, an increase of 6.5% from the previous total of 252,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Oncology Institute's float size? Oncology Institute currently has issued a total of 74,310,000 shares. Some of Oncology Institute's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oncology Institute currently has a public float of 31,090,000 shares. How does Oncology Institute's short interest compare to its competitors? 0.86% of Oncology Institute's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Oncology Institute: Pono Capital Two, Inc. (4.78%), SHL Telemedicine Ltd. (0.00%), Safety Shot, Inc. (10.78%), Lantern Pharma Inc. (6.15%), Turnstone Biologics Corp. (5.22%), Pro-Dex, Inc. (0.72%), Aileron Therapeutics, Inc. (0.98%), Future Health ESG Corp. (0.00%), enVVeno Medical Corporation (6.81%), Protara Therapeutics, Inc. (5.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Oncology Institute stock? Short selling TOI is an investing strategy that aims to generate trading profit from Oncology Institute as its price is falling. TOI shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oncology Institute? A short squeeze for Oncology Institute occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TOI, which in turn drives the price of the stock up even further. How often is Oncology Institute's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TOI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Pono Capital Two Short Interest SHL Telemedicine Short Interest Safety Shot Short Interest Lantern Pharma Short Interest Turnstone Biologics Short Interest Pro-Dex Short Interest Aileron Therapeutics Short Interest Future Health ESG Short Interest enVVeno Medical Short Interest Protara Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TOI) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders